Science#03 in April 2026 EditionStructural basis of targeted protein degradation by novel molecular glue degrader complexes
Yuki Tanaka, Eleanor White, Stefan Lindner et al.
OPENSTEM EDITORIAL SUMMARY
What the research examines
Crystal structures and biophysical binding assays explain how synthetic molecular glues induce non-native neo-protein-protein interactions between the CRBN E3 ubiquitin ligase and previously undruggable transcriptional factors, triggering rapid proteasomal degradation.
Why it may matter
Expands the chemical universe of targeted protein degradation therapeutics for recalcitrant oncogenic transcription factors.
What to examine carefully
Small chemical modifications to the glue scaffold can shift cellular target selectivity toward off-target essential proteins.
Editorial scope: This is a concise, independently written introduction based on the publisher information, not a full systematic review or independent replication. It must not replace reading the original methods, limitations and conclusions.
STUDENT RESEARCH LENS · ORIGINAL OPENSTEM NOTES
Try a small, reproducible follow-up
Calculate buried surface area and binding free energies of E3 ligase-target interfaces using Rosetta molecular modeling protocols.
Questions to investigate
- What ternary complex binding cooperativity (alpha factor) was measured using surface plasmon resonance?
- Did degrader treatment result in complete target protein clearance in patient-derived tumor cell lines?
These are independently proposed educational investigations, not activities that the original research authors claim to have completed.
Publication & researcher information
JournalNature Structural & Molecular Biology
Published online2026-04-14
Authors (selected)Yuki Tanaka, Eleanor White, Stefan Lindner et al.
University / laboratoryDana-Farber Cancer Institute
CountryUnited States
Multi-author research may involve universities in several countries. Unverified institutions and contact addresses are not inferred from authors' names.